Price T Rowe Associates Inc Veru Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Veru Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 106,109 shares of VERU stock, worth $75,337. This represents 0.0% of its overall portfolio holdings.

Number of Shares
106,109
Previous 106,109 -0.0%
Holding current value
$75,337
Previous $90,000 8.89%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.76 - $1.79 $32,534 - $76,628
42,809 Added 67.63%
106,109 $90,000
Q4 2023

Feb 14, 2024
BUY
$0.67 - $1.17 $25,460 - $44,460
38,000 Added 150.2%
63,300 $46,000
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.49 $26,823 - $40,782
-27,371 Reduced 51.97%
25,300 $31,000
Q1 2023

May 15, 2023
BUY
$1.16 - $6.41 $13,699 - $75,702
11,810 Added 28.9%
52,671 $62,000
Q4 2022

Feb 14, 2023
BUY
$4.78 - $15.01 $6,352 - $19,948
1,329 Added 3.36%
40,861 $216,000
Q3 2022

Nov 14, 2022
SELL
$10.22 - $23.7 $421,595 - $977,672
-41,252 Reduced 51.06%
39,532 $456,000
Q2 2022

Aug 15, 2022
BUY
$4.35 - $15.85 $58,281 - $212,358
13,398 Added 19.88%
80,784 $913,000
Q1 2022

May 16, 2022
BUY
$4.55 - $6.41 $7,280 - $10,256
1,600 Added 2.43%
67,386 $325,000
Q4 2021

Feb 14, 2022
BUY
$5.89 - $9.73 $91,571 - $151,272
15,547 Added 30.95%
65,786 $387,000
Q3 2021

Nov 15, 2021
BUY
$6.78 - $9.89 $75,258 - $109,779
11,100 Added 28.36%
50,239 $429,000
Q2 2021

Aug 16, 2021
BUY
$7.24 - $11.2 $59,939 - $92,724
8,279 Added 26.83%
39,139 $316,000
Q1 2021

May 17, 2021
SELL
$8.05 - $20.78 $26,637 - $68,761
-3,309 Reduced 9.68%
30,860 $333,000
Q4 2020

Feb 16, 2021
BUY
$2.36 - $9.99 $80,638 - $341,348
34,169 New
34,169 $296,000

Others Institutions Holding VERU

# of Institutions
123
Shares Held
56.9M
Call Options Held
668K
Put Options Held
531K
View Full List

About VERU INC.

VERU Quotes by TradingView
  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email